Obesity :: Metabolic syndrome common in teens
Nearly one third of overweight or obese teenagers have the metabolic syndrome, a cluster of disorders that raise the risk of developing heart disease and diabetes, according to a new report.
Nearly one third of overweight or obese teenagers have the metabolic syndrome, a cluster of disorders that raise the risk of developing heart disease and diabetes, according to a new report.
Researchers have identified a genetic factor that can help predict whether a woman will suffer a risky pregnancy.
The causes of breast cancer are still being researched, although it is known that a woman’s lifetime exposure to estrogen and her age at the time of her first childbirth play an important role.
Scientists said they have developed a computer program that can predict whether women have a high risk of developing breast or ovarian cancer. By using detailed family history, the program called BOADICEA selects women who are most susceptible to the illness and would benefit from further screening or treatment.
Alcohol consumption may slightly increase the risk for developing a certain type of irregular heart beat, known as atrial fibrillation, or atrial flutter.
Inner-city families can help relieve children’s asthma symptoms by making simple changes in their homes. Such steps include using pillow covers that are impermeable to dust mites, and air purifiers to get rid of tobacco smoke, mold and cat or dog allergens.
A U.S. study shows pediatricians are diagnosing and treating more children with behavioral health problems, such as Attention Deficit Hyperactivity Disorder.
Diabetes triples the likelihood that postmenopausal women with coronary heart disease will develop heart failure, according to a study published in Circulation.
Pregnant women suffering from epilepsy need to better informed about the risks of birth defects from treatments used to control their seizures.
A three-year study to validate a test to detect the recurrence of bladder cancer has been initiated by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), at 12 centers* across the United States and Canada. This test was conceived and is being conducted by NCI’s Early Detection Research Network (EDRN). By examining genetic changes in DNA obtained through urine samples, the test, if successfully validated, will provide a sensitive and non- invasive method of screening for bladder cancer recurrence.